January 25, 2021 22:22 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Govt remains singularly devoted to farmers’ welfare, says Prez Kovind in address to nation | Groping without skin-to-skin contact not sexual assault: Bombay HC | Indian, Chinese soldiers clash in Sikkim's Naku La, injuries reported on both sides | Delhi Police gives nod for tractor rally on Republic Day | 'Netaji an inspiration for Atmanirbhar Bharat and Sonar Bangla': PM Modi in Kolkata
Moderna to apply for emergency authorisation in US and Europe after Covid vaccine shows 100 pc efficacy iagainst severe cases Moderna

Moderna to apply for emergency authorisation in US and Europe after Covid vaccine shows 100 pc efficacy iagainst severe cases

India Blooms News Service | @indiablooms | 30 Nov 2020, 11:13 pm

Washington/IBNS: Drug manufacturer Moderna has said after full results of a late stage study showed its Covid-19 vaccine has 94.1% effectiveness and no serious safety concerns, it has decided to apply for US and European emergency authorization on Monday, said a Reuters report.

The company also reported that the vaccine showed consistent efficacy across gender, race, ethnicity and age demographics and proved 100 per cent efficient in protecting against severe cases of the disease that has so far claimed 1.5 million people across the globe, said the report.

Earlier, Pfizer and BioNTech, which had a 95% efficacy rate in trials, received emergency use authorization in the US this year.

According to the report, out of the 196 volunteers who contracted COVID-19 in the trial with more than 30,000 people, 185 were administered a placebo while 11 were given the vaccine.

Moderna said it had 30 severe cases, all of whom were in the placebo group, indicating 100% effectiveness of the vaccine in preventing severe cases.